Ira Zackon, MD, discusses bispecific antibody use in multiple myeloma among community practices, reflecting real-world treatment trends.
Ira Zackon, MD
Advertisement
Ira Zackon, MD, is a senior medical director at Ontada.
Articles by Ira Zackon, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
2
FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance
3
Respiratory Biologics Linked to Reduced Asthma Exacerbations Across Patient Groups
4
ATTR-CM Incidence, Prevalence Rose Sharply in the US
5